PeptideStack
5.2kquestions
20kanswers
220users

What is the reported incidence of nausea on tirzepatide in SURMOUNT-2?

Asked 11 Apr 2024Modified 2.3 years agoViewed 27k times
27

The case in front of me: nausea · tirzepatide · SURMOUNT-2.

The figures are clear enough; the question is what they mean and what they do not.

I can supply the numbers if the specifics change the answer.

How should I read this, and where are the traps?

gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

416 questionsclinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questionsnausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

346 questions
shareeditfollowflag
PC
askedpk_curve12k1511 Apr 2024

No answers yet

This question has not been answered. It has been viewed 27k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.